Very cool article summarizing potential of remdesivir as potential therapeutic vs Covid19. Submitted 16-Feb-2020, published 6-Mar-2020, and as of today 15-Mar-2

Very cool article summarizing potential of remdesivir as potential therapeutic vs Covid19. Submitted 16-Feb-2020, published 6-Mar-2020, and as of today 15-Mar-2020, it is the third-most-recently published article about remdesivir vs covid19 as indexed by google scholar [1]. interesting notes: remdesivir was given to the first reported covid19 patient in the usa under a compassionate use exception. Impossible to say if it helped, but the patient's condition did improve the next day. > "Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development) was initiated on the evening of day 7 (illness day 11), and no adverse events were observed in association with the infusion." [2] Also see "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)" [3] [1] https://scholar.google.com/scholar?hl=en&as_sdt=0,5&q=remdesivir+&scisbd=1 https://scholar.google.com/scholar?hl=en&as_sdt=0,5&q=remdes... [2] https://www.nejm.org/doi/10.1056/NEJMoa2001191 https://www.nejm.org/doi/10.1056/NEJMoa2001191 [3] https://www.nature.com/articles/d41573-020-00016-0 https://www.nature.com/articles/d41573-020-00016-0